Dimitry Polyntsev possesses extensive experience in business development within the pharmaceutical and healthcare sectors. Currently, Dimitry serves as the Head of Business Development for Brands and Innovative Assets at Viatris, a global healthcare company formed through the merger of Mylan and Upjohn. Prior to this role, Dimitry held senior leadership positions at Mylan as Senior Director of Global Business Development and at Forest Laboratories, where responsibilities included Director of Business Development/M&A and Senior Manager of New Product Licensing. Dimitry's academic background includes a Bachelor of Science in Business from the University of New Haven and an MBA from Thunderbird School of Global Management.
This person is not in the org chart
This person is not in any offices